معرفی
Dr. Andrew Shaw is an Associate Professor of Physical Chemistry in the School of Biosciences at the University of Exeter, where he develops quantitative screening technologies for biomarker detection in blood to advance medical diagnostics. His work bridges physical chemistry with biological applications, targeting disease diagnosis, allergy detection, and vaccine efficacy assessment.
His academic foundation includes a PhD in Physical Chemistry from the University of Southampton (1989-1992) and an MA in Natural Sciences from the University of Cambridge (1985-1988, 1992).
Shaw's research pioneers three core technologies: evanescent wave cavity ring-down spectroscopy, label-free biophotonic array screening, and lens-less microscope screening for phenotype variability. These innovations enable quantitative analysis of complex biological systems like blood, with applications spanning autoimmune disease diagnosis, surgical complication monitoring, and homeland security. He maintains dual expertise in biomedical diagnostics and astrochemistry, authoring the textbook "Astrochemistry: From Astronomy to Astrobiology" (Wiley, 2006).
His professional distinctions include:
- Fellow of the Royal Astronomical Society (1999)
- Member of the Royal Society of Chemistry (1994)
Shaw actively commercializes research through two spin-out companies: EvanesCo Ltd (founded 2002) for biophotonic screening technology and Attomarker Ltd (founded 2007) for biomarker detection systems, targeting petrochemical, medical, and security markets. He leads the Molecular Cell Biology, Biocatalysis and Biochemistry research group and serves as Study Abroad Tutor for international exchange programs.
